Welcome to our dedicated page for CDW news (Ticker: CDW), a resource for investors and traders seeking the latest updates and insights on CDW stock.
CDW Corp (CDW) delivers integrated IT solutions to businesses, government agencies, and educational institutions across North America and the UK. This news hub provides investors and technology professionals with centralized access to corporate developments shaping the digital infrastructure landscape.
Track official press releases covering earnings announcements, product launches, and strategic partnerships. Stay informed about CDW’s initiatives in cloud migration, cybersecurity enhancements, and hybrid workplace solutions through verified updates.
The repository includes filings related to public sector contracts, technology certifications, and leadership changes. Content is organized chronologically to help users monitor the company’s response to evolving IT demands across its Corporate, Public, and international segments.
Bookmark this page for streamlined access to CDW’s latest operational milestones, ensuring you remain current on developments affecting one of North America’s leading multi-brand technology providers.
Medexus Pharmaceuticals announces FDA approval of GRAFAPEX (treosulfan), an alkylating agent used with fludarabine for allogeneic hematopoietic stem cell transplantation in AML or MDS patients. The drug holds Orphan Drug Designation, providing up to 7.5 years of regulatory exclusivity.
The company targets commercial launch in first half of 2025, projecting annual product-level revenue to exceed $100 million within five years. A $15 million regulatory milestone payment to medac GmbH will be made in installments: $2.5M by June 2025, $5M by October 2025, and $7.5M by January 2026.
Preliminary Q3 2025 estimates show revenue between $29.5-30.5 million (17% YoY increase), Adjusted EBITDA of $5.5-6.0 million (70% YoY increase), and operating income of $3.5-4.0 million (123% YoY increase). The company reports $8.5 million in available liquidity as of December 31, 2024.
CDW (Nasdaq: CDW), a leading multi-brand provider of information technology solutions, has announced it will host a webcast conference call to discuss its fourth quarter and full year 2024 results on Wednesday, February 5, 2025, at 7:30 a.m. CT/8:30 a.m. ET.
The live webcast, which will include audio and slides, will be accessible at investor.CDW.com. The company will post the press release and presentation slides on the website before the call. Investors are advised to register and download necessary software at least fifteen minutes before the call. A recorded replay will be available on the website after the event.
Great Hill Partners has announced the sale of Mission Cloud Services to CDW (NASDAQ: CDW). Mission Cloud Services, founded in partnership with Simon Anderson, has grown to become the largest independent AWS managed services company in the United States. The company specializes in cloud professional services, managed services, and consulting, particularly for Amazon Web Services customers. As an AWS-certified generative AI partner, Mission offers AI and Machine Learning solutions with comprehensive protection for AWS-managed environments. Great Hill Partners initially invested in Mission in 2017 and strengthened its market position through three strategic technology company acquisitions from 2017-2019.
CDW has acquired Mission Cloud Services, an AWS Premier Tier Partner specializing in cloud professional services, managed services, and consulting. The acquisition enhances CDW Digital Velocity's cloud, data, AI, and software platform engineering capabilities. Mission, founded in 2017, will become CDW's dedicated AWS practice, bringing expertise in customized solutions for small business and mid-market AWS customers. As an AWS-certified generative AI partner, Mission offers AI/ML solutions and security services for AWS environments. The merger combines their AWS expertise, with a total of 17 AWS Competencies.
CDW (Nasdaq: CDW) announced that its CEO Christine A. Leahy and CFO Albert J. Miralles will participate in a Q&A session at the UBS Global Technology and AI Conference. The event will take place at The Phoenician in Scottsdale, Arizona on December 3, 2024, at 10:35 a.m. CT. The session will be webcast live on investor.cdw.com, with the recording available for 180 days after the event. CDW is a leading multi-brand provider of IT solutions serving business, government, education, and healthcare customers across the US, UK, and Canada.
CDW Canada's new research reveals significant unauthorized use of Generative AI (GenAI) tools in Canadian workplaces. The study shows 47 percent of Canadian workers are using unregulated AI tools, with 33 percent using them weekly. Employee confidence in AI increases when organizations take the lead, with 61 percent feeling comfortable when tools are officially implemented.
The research highlights that mid and senior-level employees are the primary users of unapproved GenAI tools, with 38 percent and 37 percent respectively using them without approval. While 36 percent of organizations plan to implement AI tools, 73 percent haven't sought third-party support, putting pressure on internal IT teams.
CDW has announced a quarterly cash dividend increase of 1% to $0.625 per share, payable on December 10, 2024, to stockholders of record as of November 25, 2024. The dividend aligns with the company's target of 25% of trailing-twelve-month Non-GAAP net income through September 30, 2024. Since its IPO in 2013, CDW's dividend has grown nearly fifteen-fold with eleven consecutive years of increases. The company has returned approximately $6.9 billion to stockholders through share repurchases and dividends.
CDW reported third quarter 2024 financial results with net sales of $5.52 billion, down 2.0% from Q3 2023. The company maintained a gross profit margin of 21.8%, while operating income increased slightly by 0.7% to $482 million. Net income remained stable at $316 million, with earnings per diluted share increasing 1.0% to $2.34. The decline in net sales was primarily driven by lower performance in Public and Corporate segments, partially offset by growth in UK and Canadian operations. The company announced a quarterly cash dividend of $0.625 per share.
CDW announced key changes to its executive leadership team as part of its succession planning strategy. Chief Commercial and Operating Officer Chris Corley will transition to a new role as President, International and Vice Chair, focusing on accelerating the company's growth strategy and international businesses. Liz Connelly will expand her responsibilities as Chief Commercial Officer, overseeing U.S. sales, sales enablement, integrated technology solutions, and digital velocity. Connelly joined CDW in 2018 after a successful career at J.P. Morgan Chase.
CDW (Nasdaq: CDW), a leading multi-brand provider of information technology solutions, has announced it will host a webcast conference call to discuss its third quarter 2024 results on Wednesday, October 30, 2024, at 7:30 a.m. CT/8:30 a.m. ET. The live webcast, including audio and slides, will be accessible at investor.CDW.com.
The press release and presentation slides will be posted on the website prior to the call. Interested parties are advised to visit the website at least fifteen minutes before the call to register and download any necessary software. A taped replay of the webcast will be available on the website shortly after the call concludes. For any questions, investors can email investorrelations@cdw.com.